Irritable bowel syndrome (IBS) is a functional GI disorder characterized by abdominal pain and altered bowel habits in the absence of a specific and unique organic pathology, rarely associated with microscopic inflammation. Studies have revealed that IBS is a disorder that affects all ages, although most patients have their first symptom before the age of 45. Women are diagnosed with IBS 2 to 3 times as often as men and make up to 80% of the population with severe IBS. Considering this, the study was undertaken to evaluate the efficacy of matra basti, followed by Laghu gangadhara churna as shamanoushadhi in the Management of Irritable bowel syndrome vis-à-vis Pravahika. It was an observational clinical study with pre and post-test design, consisting of Masura ghrita Matra Basti and Laghu gangadhara churna as shamanoushadhi. The symptoms like, Tenesmus (kunthanasheela mala pravritti), constipation (Baddha mala pravritti), abdominal pain/discomfort (Udarashoola), mucus in stool, gas/ flatulence, and increased frequency of defecation on grading were taken as parameters of assessment. The study consisted of 20 subjects and 2 assessments i.e on 0 th day and on 31 st day. Statistical results on parameters showed highly significant results on symptoms of abdominal pain/discomfort, tenesmus and flatulence with p value 0.000, and statistically significant result on symptom of mucus in stool, constipation, and increased frequency of defecation with p value 0.012, 0.009, and 0.005 respectively.
INTRODUCTION
Irritable bowel syndrome is a functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in the absence of detectable structural abnormalities.
Throughout the world about 10-20% of adult and adolescents have symptoms consistent with IBS and most studies show a female predominance. 1 In south Asia and in India, most IBS reporting patients are young men. 2 Almost all the symptoms of IBS are similar to that of Pravahika. Pravahika is a disease related to pakvashaya characterized by pravahana during defecation associated with shoola, daha and vibaddhavatavarchas. The pureesha will be picchila, saphena, sakapha and excreted in little quantity with frequent episodes. 3, 4 For Pakvashaya gata vikaras and vataja disorders, Bastichikitsa is considered to be one of the best methods of treatment. As IBS is a motility disorder related to colon (pakwashaya) which is chronic in nature and the main dosha involved in the pathogenesis of pravahika is vatadosha, this study was undertaken to evaluate the efficacy of Masura ghrita matra basti followed by Laghu gangadhara churna as shamanoushadhi in the Management of Irritable bowel syndrome vis-à-vis Pravahika.
Efficacy was assessed on the relief of symptoms like, Tenesmus (kunthanasheela mala pravritti), constipation (Baddha mala pravritti), abdominal pain/discomfort (Udarashoola), mucus in stool, Gas/ Flatulence, increased frequency of defecation by giving different grades for its severity. Observations were recorded before intervention (0 day) and after intervention (31 st day). The results were tabulated and analyzed statistically.
A total number of 20 subjects completed the intervention. Subjective improvement in IBS patients with statistical analysis of results has been explained in clinical study. All the observations were recorded in a specially designed proforma.
Statistical results on parameters showed highly significant results on symptoms of abdominal pain/discomfort, tenesmus, and flatulence with p value 0.000, and statistically significant result on symptom of constipation, mucus in stool and increased frequency of defecation with p value 0.009, 0.012 and 0.005 respectively.
OBJECTIVES OF THE STUDY
To evaluate the combined effect of Masura ghrita Matrabasti and Laghu gangadhara churna as shamanoushadhi in IBS vis-à-vis Pravahika. 
MATERIALS & METHODS Source of data

Sample size and Sampling method
A total of 22 subjects irrespective of gender, socio-economic status and religion, having the signs and symptoms of Irritable Bowel Syndrome vis-à-vis Pravahika fulfilling the inclusion criteria were registered for the study. The selected subject's detailed profile was prepared as per the detailed proforma designed for the same purpose, which incorporates relevant data like symptomatology, physical signs, laboratory investigation reports as well as assessment criteria after taking informed Consent of the subject. Out of 22 subjects registered, there were 2 dropouts at various levels of the study, and the study was completed with 20 subjects. Among 2 dropouts 1 subject discontinued after basti karma as there was no relief and 1 subject discontinued during basti karma because of unknown reason.
Research design
The present study was an observational clinical trial with Pre and Post-test design.
Intervention
The interventions were as follows.
1. Matrabasti with Masura ghrita 5 for first 8 consecutive days. 2. Laghu gangadhara churna 6 12gms in two divided doses of 6gms in the morning and 6gms in the night after food with takra as anupana for 22 days from 9 th day of intervention.
Period of intervention-30 days
Inclusion Criteria
Patients with symptoms of IBS vis-à-vis pravahika
• Abdominal pain associated with altered bowel habit that consists of constipation, diarrhoea or both. (Sashoola mala pravritti /Vibaddha mala pravritti).
• Mucus in stool (Sakapha mala pravritti).
• Altered stool passage (straining, urgency or feeling of incomplete evacuation / kunthana sheela mala pravritti/ Krute api akruta sangya).
• Cases with or without dyspepsia, nausea, vomiting, flatulence were taken for the study.
• Patients between the age group of 16-60yrs were selected.
• Patients of all gender, religion, occupation were selected for the study.
• Both fresh and treated cases were taken for the study.
Exclusion Criteria
• Patients suffering from any other systemic disorders which interfere with the course of the intervention were excluded.
• Patients with complications of IBS like haemorrhoids, depression, and weight loss were excluded.
• Patients with upadrava of Pravahika like gudabramsha, gudapaka, gudashotha, gudena rakta srava were excluded.
• Pregnant and lactating women were excluded.
Diagnostic Criteria
Rome III criteria for functional bowel disorders. The diagnosis was made based on the Rome III criteria. Recurrent abdominal pain or discomfort lasting at least 3 days a month in the last 3 months associated with any two below mentioned features  Relieved with defecation  Onset associated with a change in frequency of stool  Associated with a change in form (appearance) of stool Symptoms that support the diagnosis of IBS • Altered stool frequency (may be defined as greater than 3 bowel movement/ day and less than 3 bowel movements/ week).
• Altered stool form (lumpy/hard or loose watery stool) • Altered stool passage (straining, urgency or feeling of incomplete evacuation-kunthanasheela, Sashooloa mala pravrutti, Krute api akruta sangya).
• Passage of mucus -Sakapha/saphena mala pravritti.
• Bloating or feeling of abdominal distension.
ASSESSMENT
Parameters of assessment
Assessment was done based on clinical grading of signs and symptoms of Irritable Bowel Syndrome vis-à-vis Pravahika. These data were collected on 0 th day (Before), and on 31 st day (After completion) of intervention.
Assessment schedule
In this Study, total two assessments of the subjects were done. Before starting the Intervention i.e. pre-test assessment was done on 0 th day and post-test assessment i.e. after the completion of intervention was done on 31 st day.
Statistical methods
The results were analysed statistically by using Cross tabulation (Cremer's V test and Delphi test) analysis using Service product for statistical solution (SPSS) for windows software.
Investigations
Haematological investigations namely Haemoglobin %, TC, DC, ESR, Random blood sugar, and Urine examinations namely Sugar, Albumin & Microscopic, Stool for Ova, Cyst and Microscopic were carried out to rule out other systemic diseases in all the cases.
OBSERVATIONS AND RESULTS
Pre-test observation
Out of 20 patients, in pre-test assessment 3(15.0%) subjects had Continuous pain not relieved by passage of flatus & stool, 17(85.0%) subjects had intermittent lower abdominal pain relieved by passage of flatus. 1(5.0%) subject had No tenesmus, 0(0.0%) subjects had rarely or occasional tenesmus, 13(65.0%) subjects had tenesmus 1-2 times/day and in 6(30.0%) subjects tenesmus was frequently present. 10(50.0%) subjects had No constipation, 1(5.0%) subject had alternative day constipation and in 6(30.0%)subjects constipation was once in 2 days and in 3(15.0%) subjects constipation was once in 3 days. 7(35.0%) subjects had Passage of large amount of mucus in stool, 13(65.0%) subjects had Passage of mucus with frequent stool. 13(65.0%) subjects had Rumbling / Gurgling sound in abdomen, 7(35.0%) subjects had Frequent abdominal distension with increased Flatulence & belching. In 5(25.0%) subjects frequency of defecation was > 6 times a day, in 8(40.0%) subjects frequency of defecation was 4-6 times a day, and in 7(35.0%) subjects frequency of defecation was 2-4 times day.
Post-test assessment
In Post-test assessment, 2(10.0%) subjects had Occasional abdominal pain and 18(90.0%) subjects were completely relieved from abdominal pain.15(75.0%) subjects had no tenesmus, 5(25.0%) subjects had occasional tenesmus. 18(90.0%) subjects had no constipation, 2(10.0%) subjects had alternative day constipation. 13(65.0%) subjects had no visible mucus in stool, 4(20.0%) subjects had visible mucus in stool and 3(15.0%) subjects had Passage of mucus with frequent stool.11(55.0%) subjects had No abdominal distension, 8(40.0%) subjects had Occasional abdominal distension, 1 (5.0%) subject had frequent abdominal distension with increased Flatulence & belching. In 11(55.0%) subjects frequency of defecation was once daily, In 9(45.0%) subjects frequency of defecation was twice daily. The result on abdominal pain/discomfort shown statistically highly significant result with p value 0.000 The result on Tenesmus shown statistically highly significant result with p value 0.000 The result on Constipation shown statistically highly significant result with p value 0.009 The result on Mucus in stool shown statistically highly significant result with p value 0.012 The result on Flatulence shown statistically highly significant result with p value 0.000 The result on increased frequency of defecation shown statistically highly significant result with p value 0.005
